Levetiracetam Actavis Group (Levetiracetam)

Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action reduces neuronal excitability and limits the spread of epileptic discharges without directly influencing ion channels, providing seizure control across various seizure types.

The dosage of levetiracetam is individualized and determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and seizure type. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Levetiracetam is classified as Pregnancy Category B, indicating that animal studies have not shown risk, but adequate human data are lacking. It may be used during pregnancy only if the potential benefit justifies the potential risk. Limited data suggest it is excreted in breast milk; breastfeeding decisions should be made with a physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details, and any necessary import documentation.

Compared with many traditional antiepileptics, levetiracetam has a distinct mechanism (SV2A binding) and a relatively favorable drug‑interaction profile. It does not induce hepatic enzymes, reducing the likelihood of interactions, and is generally well tolerated. However, individual response varies, and clinicians choose therapy based on seizure type, comorbidities, and patient tolerance.

Levetiracetam tablets should be stored at ambient temperature below 25 °C, protected from moisture and direct sunlight. Keep the product in its original packaging until use. Do not store in humid or excessively hot environments to maintain potency and stability.

Levetiracetam is administered orally, typically as tablets that can be swallowed whole with water. The dosage schedule (once, twice, or three times daily) is determined by the prescriber based on the patient’s clinical needs and renal function.

Serious adverse effects, though rare, include severe psychiatric reactions such as depression, suicidal ideation, aggression, and rare skin conditions like Stevens‑Johnson syndrome. Hematologic abnormalities like neutropenia may also occur. Patients should be monitored for mood changes, rash, or unexplained bruising and seek immediate medical attention if these arise.

Levetiracetam is contraindicated in patients with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for individuals with severe renal impairment, as dose adjustments are required. Pregnant or breastfeeding women should only use it when clearly indicated and after consulting a healthcare professional.